126
Views
45
CrossRef citations to date
0
Altmetric
Original Research

Codelivery of doxorubicin and JIP1 siRNA with novel EphA2-targeted PEGylated cationic nanoliposomes to overcome osteosarcoma multidrug resistance

, , , , &
Pages 3853-3866 | Published online: 03 Jul 2018

References

  • AndersonPMEffectiveness of radiotherapy for osteosarcoma that responds to chemotherapyMayo Clin Proc200378214514612583524
  • BielackSSCarrleDHardesJSchuckAPaulussenMBone tumors in adolescents and young adultsCurr Treat Options Oncol200891678018449804
  • BielackSSKempf-BielackBDellingGPrognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocolsJ Clin Oncol200220377679011821461
  • AndersonPMWisemanGAErlandsonLGemcitabine radio-sensitization after high-dose samarium for osteoblastic osteosarcomaClin Cancer Res20051119 pt 16895690016203780
  • YangH-WLuY-JLinK-JEGRF conjugated PEGylated nano-graphene oxide for targeted chemotherapy and photothermal therapyBiomaterials201334297204721423800742
  • VisvaderJELindemanGJCancer stem cells in solid tumours: accumulating evidence and unresolved questionsNat Rev Cancer200881075576818784658
  • De BoerJPvan EgmondPWHelderMNTargeting JNK-interacting protein 1 (JIP1) sensitises osteosarcoma to doxorubicinOncotarget20123101169118123045411
  • HeC-XTabataYGaoJ-QNon-viral gene delivery carrier and its three-dimensional transfection systemInt J Pharm20103861–223224219922780
  • XuCWangJDelivery systems for siRNA drug development in cancer therapyAsian J Pharm Sci2015101112
  • HaghiralsadatFAmoabedinyGSheikhhaMHNew liposomal doxorubicin nanoformulation for osteosarcoma: drug release kinetic study based on thermo and pH sensitivityChem Biol Drug Des201790336837928120466
  • NaderinezhadSAmoabedinyGHaghiralsadatFCo-delivery of hydrophilic and hydrophobic anticancer drugs using biocompatible pH-sensitive lipid-based nano-carriers for multidrug-resistant cancersRSC Adv20177483000830019
  • HaghiralsadatFAmoabedinyGNaderinezhadSEphA2 targeted doxorubicin-nanoliposomes for osteosarcoma treatmentPharm Res201734122891290029110283
  • ShahinMSoudyREl-SikhryHSeubertJMKaurKLavasanifarAEngineered peptides for the development of actively tumor targeted liposomal carriers of doxorubicinCancer Lett2013334228429223073474
  • HaghiralsadatFAmoabedinyGHelderMNA comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene deliveryArtif Cells Nanomed Biotechnol201846116917728376641
  • LiJLiuJGuoNZhangXReversal of multidrug resistance in breast cancer MCF-7/ADR cells by h-R3-siMDR1-PAMAM complexesInt J Pharm2016511143644527444552
  • LingGZhangTZhangPSunJHeZSynergistic and complete reversal of the multidrug resistance of mitoxantrone hydrochloride by three-in-one multifunctional lipid-sodium glycocholate nanocarriers based on simultaneous BCRP and Bcl-2 inhibitionInt J Nanomedicine201611407727601896
  • LiuJLiJLiuNIn vitro studies of phospholipid-modified PAMAM-siMDR1 complexes for the reversal of multidrug resistance in human breast cancer cellsInt J Pharm20175301–229129928619457
  • HaghiralsadatFAmoabedinyGHasanSMA novel approach on drug delivery: investigation of new nano-formulation of liposomal doxorubicin and biological evaluation of entrapped doxorubicin on various osteosarcomas cell linesCell J201719Suppl 1556528580308
  • ShimGKimM-GParkJYOhYKApplication of cationic liposomes for delivery of nucleic acidsAsian J Pharm Sci2013827280
  • NavarroGSawantRRBiswasSEssexSTros de IlarduyaCTorchilinVPP-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cellsNanomedicine (Lond)201271657822191778
  • ZhengWYinTChenQCo-delivery of Se nanoparticles and pooled SiRNAs for overcoming drug resistance mediated by P-glycoprotein and class III β-tubulin in drug-resistant breast cancersActa Biomater20163119721026612416
  • PengZWangCFangELuXWangGTongQCo-delivery of doxorubicin and SATB1 shRNA by thermosensitive magnetic cationic liposomes for gastric cancer therapyPLoS One201493e9292424675979
  • YangTLiBQiSCo-delivery of doxorubicin and Bmi1 siRNA by folate receptor targeted liposomes exhibits enhanced anti-tumor effects in vitro and in vivoTheranostics20144111096111125285163
  • JiaS-FWorthLLKleinermanESA nude mouse model of human osteosarcoma lung metastases for evaluating new therapeutic strategiesClin Exp Metastasis199917650150610763916